Recommendations on COVID-19 vaccination CoNaIn agrees on primary schedules 6 months to 3 years once authorized by National Administration of Medicines, Food and Medical Technology’(ANMAT) CoNaIn agrees to heterologous reinforcement schedules in children aged 3 and 4 years. Consensus meetings are recommended with the different scientific societies regarding vaccination of minors against COVID.

Recommendations on vaccination of children 5 - 11 years with mRNA vaccine from the Pfizer laboratory

CoNaln recommends taking 50 mcg of the Moderna booster dose for the entire target population. Maintain the 100-mcg dose for immunocompromised hosts pending data specific to this population.